Prof. Dr. Alex Straumann
Eosinophile Ösophagitis
Biedermann L, Franke A, Seibold F, Quattropani C, Straumann A, Schoepfer A, Hruz P. Eosinophile Ösophagitis. Swiss Medical Forum 2022; 22(49-50):800-804.
Dec 7, 2022Eosinophile Ösophagitis
Dec 7, 2022Swiss Medical Forum 2022; 22(49-50):800-804
Biedermann Luc, Franke Annett, Seibold Frank, Quattropani Cristiana, Straumann Alex, Schoepfer Alain, Hruz Petr
Technical feasibility, clinical effectiveness, and safety of esophageal stricture dilation using a novel endoscopic attachment cap in adults with eosinophilic esophagitis.
Schoepfer A, Henchoz S, Biedermann L, Schreiner P, Greuter T, Reinhard A, Senn J, Franke A, Burri E, Juillerat P, Simon H, Straumann A, Safroneeva E, Godat S. Technical feasibility, clinical effectiveness, and safety of esophageal stricture dilation using a novel endoscopic attachment cap in adults with eosinophilic esophagitis. Gastrointest Endosc 2021; 94:912-919.e2.
May 15, 2021Technical feasibility, clinical effectiveness, and safety of esophageal stricture dilation using a novel endoscopic attachment cap in adults with eosinophilic esophagitis.
May 15, 2021Gastrointest Endosc 2021; 94:912-919.e2
Schoepfer Alain M, Henchoz Sarah, Biedermann Luc, Schreiner Philipp, Greuter Thomas, Reinhard Antoine, Senn Jonduri, Franke Annett, Burri Emanuel, Juillerat Pascal, Simon Hans-Uwe, Straumann Alex, Safroneeva Ekaterina, Godat Sébastien
A novel proangiogenic B cell subset is increased in cancer and chronic inflammation
van de Veen W, Huntjens D, Wallimann A, Fonseca Guevara R, Spits H, Desislava I, Chang Y, Fassnacht C, Guenova E, Flatz L, Akdis C, van Splunter M, Stanić B, Herrmann M, Globinska A, Jansen K, Straumann A, Kubo T, Verschoor D, Wirz O, Castro-Giner F, Tan G, Rückert B, Ochsner U, Akdis M. A novel proangiogenic B cell subset is increased in cancer and chronic inflammation. Sci Adv 2020; 6:eaaz3559.
May 13, 2020A novel proangiogenic B cell subset is increased in cancer and chronic inflammation
May 13, 2020Sci Adv 2020; 6:eaaz3559
van de Veen Willem, Huntjens Daan, Wallimann Alexandra, Fonseca Guevara Rodney J, Spits Hergen, Desislava Ignatova, Chang Yun-Tsan, Fassnacht Christina, Guenova Emmanuella, Flatz Lukas, Akdis Cezmi A, van Splunter Marloes, Stanić Barbara, Herrmann Marietta, Globinska Anna, Jansen Kirstin, Straumann Alex, Kubo Terufumi, Verschoor Daniëlle, Wirz Oliver F, Castro-Giner Francesc, Tan Ge, Rückert Beate, Ochsner Urs, Akdis Mübeccel
Long-Term Efficacy and Safety of Certolizumab Pegol in an Unselected Crohn's Disease Population: The FACTS III Survey
Vavricka S, Biedermann L, Michetti P, Straumann A, Misselwitz B, Scharl M, Manser C, Greuter T, Zeitz J, Frei P, Borovicka J, Seibold F, Schoepfer A, Rogler G, Spasojevic M. Long-Term Efficacy and Safety of Certolizumab Pegol in an Unselected Crohn's Disease Population: The FACTS III Survey. Dig Dis 2017; 35:423-432.
Jun 9, 2017Long-Term Efficacy and Safety of Certolizumab Pegol in an Unselected Crohn's Disease Population: The FACTS III Survey
Jun 9, 2017Dig Dis 2017; 35:423-432
Vavricka Stephan R, Biedermann Luc, Michetti Pierre, Straumann Alex, Misselwitz Benjamin, Scharl Michael, Manser Christine, Greuter Thomas, Zeitz Jonas, Frei Pascal, Borovicka Jan, Seibold Frank, Schoepfer Alain M, Rogler Gerhard, Spasojevic Milos
Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study
Vavricka S, Misselwitz B, Scharl M, Heinrich H, Manser C, Safroneeva E, Raja Ali R, Rogler G, Schoepfer A, Greuter T, Zeitz J, Biedermann L, Juillerat P, Gubler M, Gantenbein C, Spoerri M, Froehlich F, Seibold F, Protic M, Michetti P, Straumann A, Fournier N. Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study. Inflamm Bowel Dis 2017
Apr 27, 2017Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study
Apr 27, 2017Inflamm Bowel Dis 2017
Vavricka Stephan R, Misselwitz Benjamin, Scharl Michael, Heinrich Henriette, Manser Christine N, Safroneeva Ekaterina, Raja Ali Raja Affendi, Rogler Gerhard, Schoepfer Alain M, Greuter Thomas, Zeitz Jonas, Biedermann Luc, Juillerat Pascal, Gubler Martin, Gantenbein Claudine, Spoerri Muriel, Froehlich Florian, Seibold Frank, Protic Marijana, Michetti Pierre, Straumann Alex, Fournier Nicolas
Endoscopic treatment of paraesophageal abscess in eosinophilic esophagitis after chest trauma
Sawatzki M, Stienen M, Straumann A, Meyenberger C, Öhlschlegel C, Binek J. Endoscopic treatment of paraesophageal abscess in eosinophilic esophagitis after chest trauma. Gastrointest Endosc 2011
Dec 7, 2011Endoscopic treatment of paraesophageal abscess in eosinophilic esophagitis after chest trauma
Dec 7, 2011Gastrointest Endosc 2011
Sawatzki Mikael, Stienen Martin N., Straumann Alex, Meyenberger Christa, Öhlschlegel Christian, Binek Janek
Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II survey
Vavricka S, Michetti P, Straumann A, Seibold F, Scharl M, Sauter B, de Saussure P, Rogler G, Manz M, Geyer M, Felley C, Binek J, Bansky G, Schoepfer A, for the Swiss IBDnet. Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II survey. Inflamm Bowel Dis 2010
Dec 22, 2010Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II survey
Dec 22, 2010Inflamm Bowel Dis 2010
Vavricka Stephan R, Michetti Pierre, Straumann Alex, Seibold Frank, Scharl Michael, Sauter Bernhard, de Saussure Philippe, Rogler Gerhard, Manz Michael, Geyer Martin, Felley Christian, Binek Janek, Bansky Georg, Schoepfer Alain M, for the Swiss IBDnet
Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: Results of the FACTS survey
Schoepfer A, Straumann A, Seibold F, Sauter B, de Saussure P, Rogler G, Manz M, Geyer M, Felley C, Binek J, Vavricka S, Michetti P. Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: Results of the FACTS survey. Inflammatory bowel diseases 2009
Dec 10, 2009Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: Results of the FACTS survey
Dec 10, 2009Inflammatory bowel diseases 2009
Schoepfer Alain M, Straumann Alex, Seibold Frank, Sauter Bernhard, de Saussure Philippe, Rogler Gerhard, Manz Michael, Geyer Martin, Felley Christian, Binek Janek, Vavricka Stephan R, Michetti Pierre